Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
359 studies found for:    TRA
Show Display Options
RSS Create an RSS feed from your search for:
TRA
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: All-Trans Retinoic Acid (ATRA)
2 Active, not recruiting Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: tretinoin;   Drug: lithium carbonate;   Other: laboratory biomarker analysis
3 Withdrawn 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
Conditions: Neuroblastoma;   Neuroendocrine Tumor
Interventions: Drug: Retinoic Acid;   Drug: Placebo
4 Completed
Has Results
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
Conditions: Photodamaged Skin;   Wrinkles
Interventions: Drug: Retinol;   Drug: Tretinoin
5 Unknown  Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
6 Completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Promyelocytic Leukemia (M3);   Childhood Acute Promyelocytic Leukemia (M3);   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: tretinoin;   Drug: daunorubicin hydrochloride;   Drug: cytarabine;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: arsenic trioxide
7 Terminated
Has Results
Atralin Gel for the Treatment of Rosacea
Condition: Rosacea
Interventions: Drug: vehicle gel;   Drug: Atralin gel
8 Terminated ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: ZD6474;   Drug: Retinoic Acid
9 Unknown  A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
Conditions: Photoaging;   Photodamage
Interventions: Drug: Adapalene;   Drug: Tretinoin
10 Completed Phase I 5-Azacytidine Plus VPA Plus ATRA
Conditions: Myelodysplastic Syndrome;   Acute Myelogenous Leukemia
Interventions: Drug: 5-Azacytidine (5-aza);   Drug: Valproic Acid;   Drug: All-Trans Retinoic Acid (ATRA)
11 Completed Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Oral isotretinoin;   Drug: Tretinoin 0,05% cream;   Drug: Sunscreen FPS 60
12 Recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Conditions: Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Childhood Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Arsenic Trioxide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride;   Other: Questionnaire Administration;   Drug: Tretinoin
13 Terminated Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin
Condition: Acne Vulgaris
Interventions: Drug: Minocycline;   Drug: Minocycline plus tretinoin
14 Recruiting Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma
Condition: Melanoma
Interventions: Drug: All-Trans Retinoic Acid;   Drug: Ipilimumab
15 Active, not recruiting Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tretinoin and Arsenic Trioxide
16 Completed Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks
Conditions: Stretch Marks;   Striae;   Treatment
Interventions: Drug: Tretinoin cream 0.005%;   Device: Superficial Dermabrasion
17 Active, not recruiting RA-2 13-cis Retinoic Acid (Isotretinoin)
Conditions: Male Infertility;   Klinefelter's Syndrome;   Y-chromosome Microdeletions
Interventions: Drug: 13-cis retinoic acid;   Drug: Calcitriol
18 Unknown  A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne
Condition: Acne Vulgaris
Interventions: Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;   Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
19 Withdrawn Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream
Condition: Medication Reaction
Intervention: Drug: Tretinoin
20 Completed Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
Conditions: Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Skin Neoplasms
Interventions: Drug: Tretinoin 0.1% cream or placebo;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years